Showing results (21-30 of 492) with videos related to
Sort By:
Pageof 50
Virulence|July 8, 2016
Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infectionRohtesh S Mehta, Katayoun RezvaniHematology. American Society of Hematology. Education Program|December 4, 2016
Can we make a better match or mismatch with KIR genotyping?Rohtesh S Mehta, Katayoun RezvaniFrontiers in Immunology|March 3, 2018
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of CancerRohtesh S Mehta, Katayoun RezvaniDrugs|September 10, 2011
Vaccination strategies in lymphomas and leukaemias: recent progressKatayoun Rezvani, Hugues de LavalladeBlood|April 7, 2007
High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effectsAgnes S M Yong, Katayoun Rezvani, Bipin N Savani, et al.British Journal of Haematology|November 20, 2020
Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunityHind Rafei, May Daher, Katayoun RezvaniBlood Advances|November 24, 2020
Next-generation cell therapies: the emerging role of CAR-NK cellsRafet Basar, May Daher, Katayoun RezvaniBone Marrow Transplantation|August 22, 2019
Mesenchymal stem cell-derived exosomes for clinical useMayela Mendt, Katayoun Rezvani, Elizabeth ShpallImmunological Reviews|August 7, 2023
Next-generation chimeric antigen receptors for T- and natural killer-cell therapies against cancerYe Li, Katayoun Rezvani, Hind RafeiHematology. American Society of Hematology. Education Program|December 4, 2020
Next-generation cell therapies: the emerging role of CAR-NK cellsRafet Basar, May Daher, Katayoun RezvaniPageof 50